Overall, our results indicate that in T2D arteries, while direct effects of high glucose on protein kinase D1 signaling could still be involved, GSK3β signaling is the primary pathway that causes upregulation of arterial TMEM16A expression. The gene discussed is PRKD1; the disease is type 2 diabetes mellitus.